MTNB icon

Matinas BioPharma
MTNB

Overview Fund Trends Analyst Outlook Journalist POV

47 hedge funds and large institutions have $27.7M invested in Matinas BioPharma in 2019 Q2 according to their latest regulatory filings, with 5 funds opening new positions, 7 increasing their positions, 13 reducing their positions, and 12 closing their positions.

New
Increased
Maintained
Reduced
Closed

less ownership

Funds ownership: →

less funds holding

Funds holding: →

less capital invested

Capital invested by funds: $ → $

less repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

58% less first-time investments, than exits

New positions opened: 5 | Existing positions closed: 12

Holders
47
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
–
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
–
Puts
–
Net Calls
Net Calls Change

Top Buyers

1
+$1.22M
2
+$171K
3
+$84.1K
4
Wells Fargo
Wells Fargo
California
+$65.8K
5
Northern Trust
Northern Trust
Illinois
+$47K

Top Sellers

1
-$1.68M
2
-$1.15M
3
-$1.14M
4
CH
CVI Holdings
Delaware
-$991K
5
Millennium Management
Millennium Management
New York
-$340K
Name Holding Trade Value Shares
Change 		Change in
Stake
26
$31K
27
$26K
28
$25K
29
$24K
30
$21K
31
$17K
32
$17K
33
$15K
34
$14K
35
$14K
36
$11K
37
$10K
38
$9K
39
$9K
40
$8.57K
41
$3K
42
$2K
43
$1K
44
$1K
45
$428
46
$23
47
–
48
–
49
–
50
–
1
2
3